Understand or prevent a condition.
The two-week pause did nothing for the antibodies. In a randomized trial of 840 adults with inflammatory arthritis, holding medicines like TNF blockers and JAK inhibitors after a COVID-19 booster left antibody responses essentially identical to continuing them, while arthritis… Read More →
Anesthesiologists have debated for years which way of keeping a patient under serves them better: a continuous intravenous drip of propofol, or the traditional anesthetic gases. A large UK trial set out to answer it in adults 50 and older… Read More →
Money worked where free medicine didn't. In a trial of 3,220 adults who smoked daily and had been referred for a lung cancer screening scan, offering up to $600 in rewards for verified quitting roughly doubled the success rate: 8.8%… Read More →
For anxiety, the trials found nothing. For post-traumatic stress disorder, nothing. For psychotic illnesses like schizophrenia, nothing. Researchers in Australia pooled every randomized trial ever run on cannabinoids, the active compounds in cannabis such as THC and CBD, as treatments… Read More →
Does holding a phone to your ear, year after year, raise your risk of brain cancer? The most comprehensive review yet says no. Commissioned by the World Health Organization, an international team combed 63 studies from 22 countries spanning 1994… Read More →
A toddler with deep cavities usually faces the drill, and often sedation or even a trip to an operating room to tolerate it. A large randomized trial now shows a gentler option holds up: a liquid called silver diamine fluoride,… Read More →
Older adults who joined falls-prevention programs combining exercise with other help, such as safety education or home modifications, fell about 26% less often than those getting usual care. That's the central result of an updated Cochrane review pooling 62 randomized… Read More →
